Latest Alzheimer's disease Stories
Highlights include additional analyses from Phase 3 and ongoing open-label studies, discovery research on the potential use of combination therapy and data on the impact of beta-amyloid imaging on
Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer's disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments.
MarketReportsOnline.com adds "Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis" report to its research store. Dallas,
LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
ATLANTA, July 1, 2014 /PRNewswire-USNewswire/ -- Second Wind Dreams® (SWD®) announces the re-launch of its Family Edition of the Virtual Dementia Tour® (VDT®).
Researchers at Duke-NUS Graduate Medical School Singapore (Duke-NUS) have found evidence that the less older adults sleep, the faster their brains age.
NEW YORK, June 30, 2014 /PRNewswire/ -- Oligomerix, Inc., a privately held company pioneering the development of disease
Without a steady supply of blood, neurons can't work.
The Alzheimer Society of Ontario is pleased about two key initiatives that have been adapted for a variety of cultural and linguistic communities: Finding Your Way™, a program to prevent wandering
Older veterans who have experienced a traumatic brain injury (TBI) are 60 percent more likely to later develop dementia than veterans without TBI.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.